UNSPSC 51183606: Insulin argine

This classification denotes a peptide hormone, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 785P1QWQ1N, chemically known as insulin (human), 30ba-l-arginine-30bb-l-arginine-, but more generally known as insulin argine, which bears US NIH Compound Identifier 16132322. European Medicines Agency schedules Insulin argine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08194MIG. Most nations, for tariff and trade purposes, schedule insulin argine under HS 29371200 and SITC 54154.

SMILES: As of Q4 2014, INSULIN ARGINE remains US FDA's Preferred Term for this commodity.

UNSPSC 51183606 Insulin argine, a Commodity code, describes pharmaceutical insulin products that state and local governments procure for public health programs, correctional facilities, and municipal health departments. The code represents a narrow, specialized pharmaceutical line within the broader insulin and diabetes-management family, typically sourced through state pharmaceutical contracts, cooperative purchasing agreements, and direct vendor relationships rather than open competitive solicitation. State and local procurement under this code centers on securing reliable supply agreements for insulin arginine formulations used in clinical settings, emergency medical services, and institutional healthcare operations where standardized pharmaceutical sourcing and price controls are priorities.

The source provided contains no recent state and local contract opportunities tagged to UNSPSC 51183606. Without posted RFP, RFQ, IFB, or ITB records, no geographic concentration, issuing-body pattern, or representative solicitation detail can be established from current procurement activity.